Mitsubishi UFJ Asset Management’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $161M | Buy |
257,450
+16,850
| +7% | +$11.5M | 0.09% | 201 |
|
|
2026
Q1 | $186M | Buy |
240,600
+15,743
| +7% | +$12.1M | 0.12% | 145 |
|
|
2025
Q4 | $175M | Buy |
224,857
+8,688
| +4% | +$5.9M | 0.12% | 143 |
|
|
2025
Q3 | $122M | Buy |
216,169
+7,106
| +3% | +$4.02M | 0.09% | 190 |
|
|
2025
Q2 | $110M | Buy |
209,063
+10,213
| +5% | +$5.7M | 0.09% | 190 |
|
|
2025
Q1 | $126M | Buy |
198,850
+21,842
| +12% | +$15M | 0.12% | 158 |
|
|
2024
Q4 | $127M | Buy |
177,008
+12,757
| +8% | +$10.7M | 0.12% | 144 |
|
|
2024
Q3 | $173M | Buy |
164,251
+15,081
| +10% | +$16.8M | 0.18% | 109 |
|
|
2024
Q2 | $157M | Buy |
149,170
+16,306
| +12% | +$15.8M | 0.19% | 105 |
|
|
2024
Q1 | $128M | Buy |
132,864
+21,528
| +19% | +$20.5M | 0.18% | 110 |
|
|
2023
Q4 | $102M | Buy |
111,336
+5,603
| +5% | +$4.61M | 0.18% | 107 |
|
|
2023
Q3 | $87M | Buy |
105,733
+8,320
| +9% | +$6.54M | 0.18% | 111 |
|
|
2023
Q2 | $70M | Buy |
97,413
+6,385
| +7% | +$4.92M | 0.15% | 122 |
|
|
2023
Q1 | $74.8M | Buy |
91,028
+8,805
| +11% | +$6.64M | 0.18% | 109 |
|
|
2022
Q4 | $59.2M | Buy |
82,223
+7,914
| +11% | +$5.84M | 0.16% | 117 |
|
|
2022
Q3 | $51.2M | Buy |
74,309
+6,822
| +10% | +$4.29M | 0.16% | 115 |
|
|
2022
Q2 | $39.9M | Buy |
67,487
+5,248
| +8% | +$3.41M | 0.18% | 120 |
|
|
2022
Q1 | $43.5M | Buy |
62,239
+5,583
| +10% | +$3.53M | 0.17% | 117 |
|
|
2021
Q4 | $35.5M | Buy |
56,656
+8,889
| +19% | +$5.47M | 0.14% | 140 |
|
|
2021
Q3 | $28.9M | Buy |
47,767
+4,541
| +11% | +$2.82M | 0.14% | 139 |
|
|
2021
Q2 | $24.1M | Buy |
43,226
+5,535
| +15% | +$2.8M | 0.13% | 159 |
|
|
2021
Q1 | $17.8M | Buy |
37,691
+4,713
| +14% | +$2.29M | 0.12% | 185 |
|
|
2020
Q4 | $15.9M | Buy |
32,978
+2,303
| +8% | +$1.24M | 0.12% | 171 |
|
|
2020
Q3 | $17.2M | Buy |
30,675
+4,462
| +17% | +$2.71M | 0.16% | 132 |
|
|
2020
Q2 | $16.3M | Buy |
26,213
+9,050
| +53% | +$5.14M | 0.19% | 112 |
|
|
2020
Q1 | $8.38M | Buy |
17,163
+26
| +0.2% | +$10.7K | 0.13% | 156 |
|
|
2019
Q4 | $6.33M | Buy |
17,137
+1,825
| +12% | +$614K | 0.08% | 245 |
|
|
2019
Q3 | $4.25M | Buy |
15,312
+830
| +6% | +$246K | 0.07% | 282 |
|
|
2019
Q2 | $4.53M | Buy |
14,482
+3,555
| +33% | +$1.18M | 0.08% | 259 |
|
|
2019
Q1 | $4.49M | Buy |
10,927
+616
| +6% | +$254K | 0.09% | 216 |
|
|
2018
Q4 | $3.84M | Sell |
10,311
-1,987
| -16% | -$727K | 0.1% | 210 |
|
|
2018
Q3 | $4.97M | Sell |
12,298
-27
| -0.2% | -$10.3K | 0.1% | 197 |
|
|
2018
Q2 | $4.25M | Buy |
12,325
+153
| +1% | +$47.9K | 0.09% | 216 |
|
|
2018
Q1 | $4.19M | Sell |
12,172
-2,106
| -15% | -$732K | 0.1% | 216 |
|
|
2017
Q4 | $5.62M | Buy |
14,278
+450
| +3% | +$182K | 0.12% | 177 |
|
|
2017
Q3 | $6.18M | Sell |
13,828
-16,532
| -54% | -$7.87M | 0.15% | 148 |
|
|
2017
Q2 | $14.9M | Sell |
30,360
-18,916
| -38% | -$8.28M | 0.37% | 57 |
|
|
2017
Q1 | $19.1M | Sell |
49,276
-7,671
| -13% | -$2.84M | 0.44% | 50 |
|
|
2016
Q4 | $21.6M | Buy |
56,947
+9
| +0% | +$3.42K | 0.53% | 46 |
|
|
2016
Q3 | $22.9M | Sell |
56,938
-8,067
| -12% | -$3.24M | 0.57% | 43 |
|
|
2016
Q2 | $22.7M | Sell |
65,005
-5,047
| -7% | -$1.94M | 0.59% | 44 |
|
|
2016
Q1 | $25.3M | Buy |
70,052
+17,579
| +34% | +$7.24M | 0.68% | 36 |
|
|
2015
Q4 | $28.5M | Sell |
52,473
-6,213
| -11% | -$3.37M | 0.82% | 26 |
|
|
2015
Q3 | $27.3M | Buy |
58,686
+49,178
| +517% | +$26.4M | 0.86% | 25 |
|
|
2015
Q2 | $4.85M | Sell |
9,508
-1,153
| -11% | -$563K | 0.15% | 136 |
|
|
2015
Q1 | $4.81M | Sell |
10,661
-549
| -5% | -$233K | 0.14% | 151 |
|
|
2014
Q4 | $4.6M | Sell |
11,210
-1,545
| -12% | -$608K | 0.14% | 156 |
|
|
2014
Q3 | $4.6M | Sell |
12,755
-2,537
| -17% | -$850K | 0.14% | 162 |
|
|
2014
Q2 | $4.32M | Buy |
15,292
+11
| +0.1% | +$3.26K | 0.11% | 206 |
|
|
2014
Q1 | $4.59M | Buy |
15,281
+1,012
| +7% | +$312K | 0.12% | 188 |
|
|
2013
Q4 | $3.88M | Sell |
14,269
-3,491
| -20% | -$1M | 0.11% | 211 |
|
|
2013
Q3 | $5.56M | Buy |
17,760
+1,260
| +8% | +$331K | 0.14% | 158 |
|
|
2013
Q2 | $3.71M | Buy |
+16,500
| New | +$3.84M | 0.11% | 224 |
|
Other funds holding REGN
Mitsubishi UFJ Asset Management's REGN Position: Q2 2026 in Review
Mitsubishi UFJ Asset Management increased its Regeneron Pharmaceuticals (REGN) stake by 7% in Q2 2026, buying an estimated $11.5M and bringing the position to 257,450 shares worth $161M. The position accounts for 0.09% of the portfolio, ranked #201.
Mitsubishi UFJ Asset Management first reported a position in REGN in Q2 2013 and has held it in 53 quarters since. The position peaked at $186M in Q1 2026. 1,332 funds tracked by Wall St. Rank hold REGN as of Q2 2026.
- Mitsubishi UFJ Asset Management held 257,450 shares of Regeneron Pharmaceuticals worth $161M as of Q2 2026.
- Mitsubishi UFJ Asset Management bought 16,850 Regeneron Pharmaceuticals shares in Q2 2026, an estimated $11.5M.
- Regeneron Pharmaceuticals made up 0.09% of Mitsubishi UFJ Asset Management's portfolio in Q2 2026, its #201 holding.
- Mitsubishi UFJ Asset Management first reported a position in Regeneron Pharmaceuticals in Q2 2013 and has held it in 53 quarters since.
- Mitsubishi UFJ Asset Management's Regeneron Pharmaceuticals position peaked at $186M in Q1 2026.
- 1,332 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.
Based on Mitsubishi UFJ Asset Management's 13F filing for Q2 2026, filed 7 Aug 2026.